Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Porebski Liposomes is a Polish biotechnology company specializing in the design, development, and manufacturing of advanced liposomal drug delivery systems. The company leverages its proprietary platform to encapsulate a wide range of active pharmaceutical ingredients, including small molecules and natural compounds, to enhance their therapeutic index, stability, and bioavailability. Porebski Liposomes focuses primarily on applications in oncology and dermatology, providing both internal pipeline development and specialized R&D services for pharmaceutical partners. Their expertise includes the creation of stable, scalable liposomal formulations tailored for specific clinical needs and targeted delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Porebski Liposomes.